- Dr AG Jeetoo Hospital (Civil)
Port Louis, Mauritius - Mon - Sat 8.00 - 18.00.
Sunday CLOSED
News & Events
Upcoming CRC Screening
Colorectal Cancer ranks as the third most commonly diagnosed cancer in Mauritius. Approximately 1 in 23 individuals in the general population will face a bowel cancer diagnosis at some point, affecting both men and women equally. Sadly, in Mauritius, only about 75% of patients diagnosed with bowel cancer survive beyond 2 years, underscoring the urgency of early detection to prevent fatalities from this disease.
Read More
HCV training session
Hepatitis C Virus (HCV) is a silent threat, claiming more lives from liver disease than alcohol in Mauritius, yet it often goes unnoticed by many. However, early detection can lead to highly effective treatment, allowing individuals to live normal lives thereafter.
Read More
Gilead Visit
In January 2020, a significant milestone was achieved in Mauritius's healthcare landscape when Prime Minister Honorable Pravin Jugnauth signed an agreement with Gilead Sciences. This agreement secured a donation of the state-of-the-art drug EPCLUSA, capable of treating over 98% of Hepatitis C patients in just three months. Unlike previous treatments, EPCLUSA is pan-genotypic, meaning it can cure patients regardless of their specific genotype, streamlining treatment pathways and minimizing side effects.
Read More
Hepatitis C Screening Week
The international screening week serves as a valuable reminder of the importance of getting tested for everyone involved, including the patient and their loved ones. It's also a crucial time for both government and non-governmental organizations to reflect on and evaluate their efforts over the past year.
Read More
CRC Conference
Colorectal Cancer is a significant health concern in Mauritius, ranking as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths. It affects both men and women equally and is typically diagnosed around the age of 67. The majority of colorectal cancers develop from precancerous adenomas, making early detection crucial for prevention.
Read More
HCV Conference
Before 2018, treating Hepatitis C in Mauritius was complex, with limited access to care and unclear referral routes. Only one center provided treatment, and from 2005 to 2018, merely about 100 patients received it. Recognizing the urgency to meet WHO's goal of eliminating Hepatitis C by 2030, significant changes were imperative.
Read More